More than Half of the U.S. House Asks Azar to Address Drug Makers’ 340B Actions Immediately
More than half of the U.S. House today told U.S. Health and Human Services (HHS) Secretary Alex Azar “it is imperative that immediate action
…More than half of the U.S. House today told U.S. Health and Human Services (HHS) Secretary Alex Azar “it is imperative that immediate action
…Note from the Publisher and CEO Ted Slafsky: I want to acknowledge this date, Sept. 11, and its solemn importance to our country. We honor those who were lost 19 years ago today and continue to cherish the great work of
…The National Association of Community Health Centers (NACHC) “is preparing legal action” in response to drug manufacturers’ recent unilateral moves to stop providing reduced 340B pricing on their products
…Letting drug manufacturers “pick and choose” which 340B program requirements they will comply with “could set us on a treacherous path where program participants might disregard
…Note from the Publisher and CEO Ted Slafsky: We are still collecting reaction from our breaking story last night but have plenty of other news and information in today’s issue. Due to the Labor Day holiday, we
…In a major development, the Health Resources and Services Administration (HRSA) has told 340B Report that it is investigating whether recent manufacturer policies to restrict
…After publication, 340B Report received the following comment from Eli Lilly and Co. on its actions that we reported on today:
…Report after report shows 340B is not working for patients and needs reform. We support recent executive action on
Note from the Publisher and CEO Ted Slafsky: Bronwyn Mixter is filling in for Tom Mirga this week. If you have story ideas or tips, feel free to reach her at bronwyn.mixter@340breport.com or 703-403-5926. We’re pleased to include
…Note from the Publisher and CEO: Happy Wednesday. Bronwyn Mixter is filling in for Tom Mirga this week and next week. If you have story ideas or tips, feel free to reach her at bronwyn.mixter@340breport.com or 703-403-5926.
*Sign up for news summaries and alerts from 340B Report